Page 20 - BH-2-3

Brain & Heart Cerebral ischemia biomarkers

Consent for publication J Stroke Cerebrovasc Dis. 2020;29(9):105055.

Not applicable. doi: 10.1016/j.jstrokecerebrovasdis.2020.105055
13. Jin WN. Proteomic identification of biomarkers in the
Availability of data cerebrospinal fluid of acute ischemic stroke patients. Front

Not applicable. Aging Neurosci. 2019;11:236.
14. Roos N. Copeptin as a marker of severity and prognosis in
References patients with organ dysfunction in the intensive care unit.

1. Zhao Y, Zhang X, Chen X, Wei Y. Neuronal injuries in Crit Care. 2015;19(1):93.
cerebral infarction and ischemic stroke: From mechanisms 15. Zhou C, Zhou F, He Y, Liu Y, Cao Y. Exosomes in cerebral
to treatment (Review). Int J Mol Med. 2022;49(2):15. ischemia-reperfusion injury: Current perspectives and
future challenges. Brain Sci. 2022;12(12):1657. doi:
doi: 10.3892/ijmm.2021.5070
10.3390/brainsci12121657
2. Bivard A, Levi C, Krings T, et al. Neuroimaging standards for
acute stroke patients: An update. Int J Stroke. 2018;13(6):612- 16. Mitrečić D, Hribljan V, Jagečić D, et al. Regenerative
620. neurology and regenerative cardiology: Shared hurdles and
achievements. Int J Mol Sci. 2022;23(2):855.
3. Schaeffer JJ, Leach JL, Aygun N. Neuroimaging of ischemic
injury in stroke: A review for the clinician. Front Neurol. doi: 10.3390/ijms23020855
2020;11:190. 17. Yin J. Cerebrospinal fluid metabolomics identifies a key role
4. Campbell BC, Parsons MW. Imaging selection for acute of glyoxylate pathway and pantothenate for mitochondrial
stroke intervention. Int J Stroke. 2018;13(6):554-567. doi: dysfunction in experimental stroke. Cell Death Dis.
10.1177/1747493018765235 2016;7(2):e2166.
18. Shin TH, Lee DY, Basith S, et al. Metabolome changes in
5. Schirmer MD, Donahue KL, Nardin MJ, et al. Perfusion
imaging versus diffusion-weighted imaging in transient cerebral ischemia. Cells. 2020;9(7):1630. doi: 10.3390/
ischemic attack: Is it time to change the guidelines? Stroke. cells9071630
2017;48(3):556-563. 19. Lin QY. Metabolomic analysis reveals potential biomarkers
6. Heldner MR. How to identify stroke mimics in and metabolic changes in experimental cerebral ischemia.
patients eligible for intravenous thrombolysis? J Stroke. Metabolomics. 2018;14(4):57.
2020;22(1):70-79. 20. Wuolikainen A. Multi-platform mass spectrometry analysis
7. Smith LGF, Milliron E, Ho ML, et al. Advanced neuroimaging of the CSF and plasma metabolomes of rigorously matched
in traumatic brain injury: An overview. Neurosurg Focus. amyotrophic lateral sclerosis, Parkinson’s disease, and
2019;47(6):E17. control subjects. Mol BioSystems. 2016;12(4):1287-1298.
21. Dagonnier M, Donnan GA, Davis SM, Dewey HM, Howells
doi: 10.3171/2019.9.FOCUS19652
DW. Acute stroke biomarkers: Are we there yet? Front
8. Pluta R, Ułamek-Kozioł M. Genes associated with Alzheimer’s Neurol. 2021;12:619721.
disease in post-ischemic brain neurodegeneration. In: Pluta
R, editor. Cerebral Ischemia. Ch. 3. Brisbane, AU: Exon doi: 10.3389/fneur.2021.619721
Publications; 2021. 22. Hu Y, Ni Z, Yu ZX, et al. Exploration of urine metabolomic
9. Kimura R. Variants in MTHFR gene are and genetic profiling as potential diagnostic tool for ischemic stroke.
susceptibility to ischemic stroke: A meta-analysis. J Clin Cell Physiol Biochem. 2018;50(6):2126-2136.
Neurosci. 2018;47:158-165. 23. Fan S. A urinary metabolite constellation characteristic of
brain arteriovenous malformation patients. Hypertension.
10. Yao H, Zhang W, Jiang X, et al. Differential expression
analysis of ATP5H in stroke and the development of ischemic 2017;69(6):1209-1216.
tolerance. J Stroke Cerebrovas Dis. 2020;29(11):105090. 24. D’Souza K, Paramel GV, Kienesberger PC. Impact of
metabolomics on renal diseases: Where are we and where
11. Cai Y, Zhuang YK, Wu XY, et al. Serum hypoxia-
inducible factor 1alpha levels correlate with outcomes can it lead us? Int J Mol Sci. 2019;20(3):E573.
after intracerebral hemorrhage. Ther Clin Risk Manag. 25. Guan L. DNA methylation located in CpG sites involved
2021;17:717-726. in stroke: A genome-scale analysis. Front Genet.
2020;11:589560.
doi: 10.2147/TCRM.S313433
26. Bolton ML. Epigenetic control of stroke recovery.
12. Wang J, Jiang Y, Zeng D, Zhou W, Hong X. Prognostic value
of plasma HMGB1 in ischemic stroke patients with cerebral Epigenomics. 2014;6(2):179-194.
ischemia-reperfusion injury after intravenous thrombolysis. 27. Millar DS. Next-generation epigenomics: From sequencing

Volume 2 Issue 3 (2024) 14 doi: 10.36922/bh.2750